Pharmacogenetics is the study of how genetic differences among individuals cause varied responses to a drug. Occasionally these responses are in the form of unwanted side effects. Doctors do their best to prescribe medications in dosages appropriate to their patient. Using information such as known allergies, blood type, age, and gender to make these treatment decisions. However, if a provider were able to peek into the genetic makeup of their patient as well it would paint a much more accurate picture. The genetics of a person will reveal how that individual will react to a medication whether it be a positive or negative outcome. Taking this measure would help to prevent the unwanted side effects.
• Upper respiratory infection is responsible for many life-threatening illnesses. The Flu and other series u and other serious pulmonary infections affect 5 million people annually, killing 500,000.
• Treatments vary greatly for bacterial or viral infections – Identification of the pathogen is necessary for rapid appropriate intervention, to limit the duration and severity of symptoms.
• Antibiotic resistance, accelerated by the needless use of antibiotics during a viral infection, is cited by the World Health Organization as a major threat to global public health.
Reveal diagnostic offers a multiplexed molecular respiratory pathogen panel developed to broaden and streamline testing for multiple viral and bacterial agents of the upper respiratory tract. The test is performed by nasopharyngeal swab and provides more information quickly and accurately.
BENEFITS OF RPP TESTING
• RPP by PCRtesting identifies causative organism/bacteria/pathogen by its DNA/RNA – which makes it possible to quickly diagnosis the type of infection.
• RPP testing is a useful tool in avoiding over prescribing of antibiotics.
• Average of 24-48 hour turnaround time